Autism Impact Fund

Unison Therapy Services is a provider of therapeutic treatment services focused on children with autism and developmental disabilities. The company specializes in Applied Behavior Analysis (ABA) therapy and emphasizes a family-first approach. Services are delivered in various settings, including clinics, homes, and schools, ensuring accessibility and convenience for families. Unison Therapy Services operates throughout California and Colorado, aiming to support the development and well-being of children through effective therapeutic interventions.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. By collaborating with industry experts in technology and healthcare, as well as clinical leaders, parents, and payers, SpectrumAi aims to modernize the delivery of autism care. The company's innovative healthcare technology offers objective data, meaningful insights, and actionable recommendations, all designed to support patients in achieving optimal outcomes. These outcomes include fostering independent living, building meaningful relationships, pursuing lifelong vocational goals, and promoting self-advocacy. Through its efforts, SpectrumAi seeks to transform the landscape of autism treatment and improve the quality of life for individuals on the spectrum.

Healios Limited is a digital healthcare technology company based in Southampton, United Kingdom, founded in 2013. The company specializes in developing an online platform that connects mental health therapists with both children and adults, facilitating access to evidence-based psychological therapies. Healios aims to empower patients and their families by providing a clinician-led online family intervention service that offers interactive psychoeducation for caregivers. By integrating technology with specialized expertise and personal human connection, Healios seeks to enhance the delivery of mental health care and promote behavioral change. Their mission is to transform care delivery, enabling patients, families, and caregivers to move forward and improve their quality of life.

Floreo Inc., founded in 2016 and based in Washington D.C., develops a virtual reality learning app designed to teach social and communication skills to individuals with autism spectrum disorder, as well as those with ADHD and anxiety. The platform allows supervising adults to monitor and guide activities, making it a valuable tool for therapy clinics and school districts. Floreo is used by over 100 therapy clinic businesses and school districts, and has partnered with Meta to expand its reach in public schools.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. By collaborating with industry experts in technology and healthcare, as well as clinical leaders, parents, and payers, SpectrumAi aims to modernize the delivery of autism care. The company's innovative healthcare technology offers objective data, meaningful insights, and actionable recommendations, all designed to support patients in achieving optimal outcomes. These outcomes include fostering independent living, building meaningful relationships, pursuing lifelong vocational goals, and promoting self-advocacy. Through its efforts, SpectrumAi seeks to transform the landscape of autism treatment and improve the quality of life for individuals on the spectrum.

Cortica Inc. is a company dedicated to providing neurological therapies for children facing autism and other neurodevelopmental challenges. Founded in 2014 and based in San Diego, California, Cortica offers tailored treatment programs that are informed by a comprehensive understanding of each child's neurobiology and developmental profile. The company operates multiple centers across California, including locations in Carlsbad, Irvine, San Rafael, Torrance, and Westlake Village. Cortica's services encompass a wide range of assessments and therapies, including diagnoses for autism, ADHD, and developmental delays. Treatment options available include gene sequencing, metabolic testing, electroencephalography, nutrition evaluation, medication management, and various therapeutic interventions such as ABA therapy, parent coaching, speech-language therapy, occupational therapy, physical therapy, and music therapy. The company provides these services through in-home, in-clinic, and telehealth modalities.

auticon GmbH is a consulting firm based in Berlin, Germany, with additional offices in Munich and Düsseldorf. Founded in 2011, the company specializes in information technology services, particularly in software testing and quality assurance. auticon employs autistic individuals exclusively as software testers, leveraging their unique skills to provide high-quality workmanship in various areas, including static code analysis, functional testing, usability testing, and data analysis. The company's services cater to a diverse clientele, including software producers, IT firms, consulting companies, and public institutions. By focusing on the strengths of its workforce, auticon not only delivers exceptional testing services but also promotes inclusivity within the tech industry.

BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

SpectrumAi is a digital health company focused on enhancing Autism care by increasing access to high-quality Applied Behavior Analysis (ABA) therapy for children globally. By collaborating with industry experts in technology and healthcare, as well as clinical leaders, parents, and payers, SpectrumAi aims to modernize the delivery of autism care. The company's innovative healthcare technology offers objective data, meaningful insights, and actionable recommendations, all designed to support patients in achieving optimal outcomes. These outcomes include fostering independent living, building meaningful relationships, pursuing lifelong vocational goals, and promoting self-advocacy. Through its efforts, SpectrumAi seeks to transform the landscape of autism treatment and improve the quality of life for individuals on the spectrum.

Suggestic, Inc. is a San Francisco-based company founded in 2014 that specializes in automated and personalized lifestyle and nutrition coaching. Its platform leverages proprietary artificial intelligence to create tailored diet plans that cater to users' individual goals, dietary preferences, and restrictions. The application facilitates precision eating by offering personalized meal plans, smart shopping lists, recipe suggestions, and restaurant recommendations. By encoding dietary programs as rulesets, Suggestic enables health-related organizations to efficiently build and deliver customized nutrition programs through white label solutions or direct API integration. The platform also supports data acquisition from users through assessments and lab tests, allowing it to provide relevant food recommendations that assist individuals in weight management, enhancing vitality, and preventing or reversing chronic diseases.

Floreo Inc., founded in 2016 and based in Washington D.C., develops a virtual reality learning app designed to teach social and communication skills to individuals with autism spectrum disorder, as well as those with ADHD and anxiety. The platform allows supervising adults to monitor and guide activities, making it a valuable tool for therapy clinics and school districts. Floreo is used by over 100 therapy clinic businesses and school districts, and has partnered with Meta to expand its reach in public schools.

Yamo Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing innovative therapies for Autism Spectrum Disorder. The company's primary product, L1-79, is an oral treatment designed to improve core symptoms associated with the disorder. By targeting both central nervous system and metabolic symptoms, Yamo aims to modulate catecholaminergic pathways, ultimately helping individuals with Autism enhance their socialization and communication skills. Through its specialized therapeutics platform, Yamo Pharmaceuticals seeks to address significant challenges faced by those affected by Autism, providing a potential advancement in treatment options within this field.

Axial Biotherapeutics, Inc. is a biopharmaceutical company focused on developing therapeutics for central nervous system (CNS) diseases and disorders. Utilizing a microbiome discovery platform, the company targets the gut-brain axis to create innovative therapies aimed at improving the quality of life for patients suffering from neurological conditions. Founded in 2013 and headquartered in Waltham, Massachusetts, Axial Biotherapeutics is in the clinical stage of its development, working to advance its pipeline of novel CNS therapeutics.

Joshin, LLC is a Minnesota-based company that develops a digital care platform aimed at supporting individuals with disabilities and neurodivergence. The company's primary offering is an application that connects families in need of caregiving services with qualified, screened caregivers. Through this platform, users can create personalized care plans that outline the specific needs, goals, preferences, and dietary requirements of their loved ones. By facilitating these connections, Joshin aims to provide families with convenient access to specialized care and support for individuals with special needs, enhancing the overall caregiving experience.

MARAbio is a biotechnology firm focused on detecting and preventing severe forms of autism. The company specializes in maternal autoantibody-related autism testing, which aims to determine the risk of autism spectrum disorder (ASD). MARAbio's licensed technology identifies a unique cluster of antibodies in mothers that target proteins in the developing brain of children later diagnosed with ASD. This early identification allows for the initiation of beneficial behavioral therapies if developmental delays are observed in children.